Back to Search Start Over

Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.

Authors :
Ma Q
Liu J
Wu G
Teng M
Wang S
Cui M
Li Y
Source :
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2018 Oct; Vol. 45 (10), pp. 1002-1009. Date of Electronic Publication: 2018 Jul 26.
Publication Year :
2018

Abstract

Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer (CRC), Foxp3 <superscript>+</superscript> Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and in the more canonical CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> Foxp3 <superscript>+</superscript> Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin-domain containing-3 negative (LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> ) and LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subsets. In CRC patients, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subset represented approximately half of CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and greater than 60% of CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> Foxp3 <superscript>+</superscript> Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells presented considerably higher transforming growth factor-β and slightly higher interleukin (IL)-10 secretion, together with higher cytotoxic T-lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells displayed different characteristics. Macrophages incubated with LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells presented lower expression of major histocompatibility complex class II, CD80, CD86, and tumor necrosis factor-α but higher expression of IL-10, than macrophages incubated with LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> Treg cells.<br /> (© 2018 John Wiley & Sons Australia, Ltd.)

Details

Language :
English
ISSN :
1440-1681
Volume :
45
Issue :
10
Database :
MEDLINE
Journal :
Clinical and experimental pharmacology & physiology
Publication Type :
Academic Journal
Accession number :
29905955
Full Text :
https://doi.org/10.1111/1440-1681.12992